Evident Vascular Receives FDA Approval for High-Fidelity AI-Powered IVUS Imaging Platform

Evident Vascular has announced U.S. Food and Drug Administration 510(k) clearance for the Evident Vascular Guidance System and Evident peripheral imaging catheters. The Guidance System is intended for ultrasound examination of intravascular pathology during peripheral vascular interventions.

The platform is designed to bring together high-fidelity imaging, purpose-built AI, and non-disruptive workflow. Its proprietary flushless, plug-and-play catheters, intuitive user interface, and hands-free voice control are designed to support procedural efficiency.

Conventional high-definition imaging is commonly associated with image resolution and ultrasound center frequency, but center frequency alone cannot describe intravascular ultrasound image quality as it is only one part of the imaging equation. Evident’s approach integrates broad frequency bandwidth, advanced transducer design, and advanced signal processing, with proprietary DFC technology at the core providing dynamic frequency control to optimize imaging.

Sign up for Blog Updates